2-Amino-5-fluoro-4,6-dihydroxypyrimidine
Guanidine sulfate (5.95 g, 55 mmol) was added to the solution of sodium (2.50 g, 110 mmol) in anhydrous ethanol (100 mL) and the mixture was heated to reflux. Diethyl 2-fluoromalonate (8.90 g, 50 mmol, 93% pure) was added dropwise over 20 minutes and the mixture was heated at reflux for 6 h. After cooling to room temperature, the solution was evaporated to dryness, the residue was dissolved in water (20 mL), neutralised with HCl to pH 7, the precipitated product was filtered, washed with water (5 mL), ethanol (2 × 5 mL) and diethyl ether (2 × 5 mL). After drying in vacuo, 2-amino-5-fluoro-4,6-dihydroxypyrimidine (6.21 g, 86%) was obtained as a pink powder.
m.p.: >300 °C ([M + H]+, 146.0357, C4H5FN3O2 requires: [M]+, 146.0366);
IR (neat,cm−1) 3343, 3100, 2916, 2731, 1600, 1557, 1415, 1358, 1204;
δH (DMSO d6, 400 MHz) 7.00 (2H, bs, N–H), 11.1 (2H, bs, OH); δF (DMSO d6, 376 MHz): – 197.05 (s);
δC (DMSO d6, 100 MHz) 125.13 (d, 1JCF 208.6, C–F), 149.26 (d, 4JCF 2.3, C–H), 155.12 (d, 2JCF 18.0, C–OH);
m/z (ASAP) 146 (100%, [M + H]+).
(a) E. D. Bergmann, S. Cohen and I. Dharak, J. Chem. Soc., 1959, 3286–3289
http://pubs.rsc.org/en/content/articlehtml/2015/gc/c5gc00402k
DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE
amcrasto@gmail.com
//